BCL2L11 and acute lymphoblastic leukemia: Another GSI PF-03084014 in combination with dexamethasone enhanced expression of glucocorticoid target genes (RUNX2, PFKFB2, BCL-2L11, BMF, and TSC22D3) and increased the cytotoxicity of dexamethasone in vitro and in vivo in a xenograft model of glucocorticoid-resistant T-ALL [191].